This inventor holds 3 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents. Top assignee: Genome and Company. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Jinyoung Sohn: Innovator in Cancer Treatment
Introduction
Jinyoung Sohn is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work focuses on enhancing immune responses to combat cancer effectively.
Latest Patents
Jinyoung Sohn holds a patent for a pharmaceutical composition aimed at preventing or treating cancer. This composition comprises an LRIT2 inhibitor as the active ingredient. The invention is designed to increase the activity of immune cells, thereby serving as an immune enhancer. By enhancing an individual's immunity, the LRIT2 inhibitor can effectively prevent or treat cancer.
Career Highlights
Jinyoung Sohn is associated with Genome and Company, where he continues to develop groundbreaking solutions in the pharmaceutical industry. His work is pivotal in advancing cancer treatment methodologies and improving patient outcomes.
Collaborations
He collaborates with notable colleagues, including Kyoung Wan Yoon and Youn Kyung Houh, to further enhance the research and development of innovative cancer therapies.
Conclusion
Jinyoung Sohn's contributions to cancer treatment through his patented inventions highlight his role as a key innovator in the pharmaceutical field. His work not only advances scientific knowledge but also offers hope for improved cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile